Prospect Medical Layoffs: 125 Jobs Cut
- Prospect Medical Systems, currently navigating Chapter 11 bankruptcy, plans to implement a workforce reduction of 125 administrative employees in California, effective July 1.
- The move comes as Prospect Medical Holdings seeks to sell Prospect Medical Systems, its pharmacy operations, a health plan, medical groups, and a medical center to Astrana Health,...
- Earlier this year, Prospect struck a deal to sell two Rhode Island hospitals to the Centurion Foundation, a Georgia-based nonprofit, for $160 million.
Prospect Medical Systems is laying off 125 administrative staff in California,a direct result of the company’s financial struggles and Chapter 11 bankruptcy filing. The healthcare provider is actively attempting to sell its assets, including pharmacy operations and a health plan, with a deal proposed to Astrana Health for $745 million. The role of private equity, especially Leonard Green & Partners, is under scrutiny, with allegations of mismanagement and prioritizing profits over patient care. The company’s financial woes have led to hospital closures and legal battles, raising serious concerns about the future of healthcare access. News Directory 3 has the latest updates. Discover what’s next for Prospect and the impact on the communities they serve.
Prospect Medical Systems Announces California Layoffs Amid Financial Turmoil
Prospect Medical Systems, currently navigating Chapter 11 bankruptcy, plans to implement a workforce reduction of 125 administrative employees in California, effective July 1. The management services institution, a subsidiary of Prospect Medical holdings, oversees care for 600,000 members across 28 networks in five states.
The move comes as Prospect Medical Holdings seeks to sell Prospect Medical Systems, its pharmacy operations, a health plan, medical groups, and a medical center to Astrana Health, based in California, for $745 million. this sale is part of a broader effort to shed assets following the bankruptcy declaration, which revealed billions in liabilities.
Earlier this year, Prospect struck a deal to sell two Rhode Island hospitals to the Centurion Foundation, a Georgia-based nonprofit, for $160 million. However, attempts to find buyers for facilities in Pennsylvania and Connecticut have been unsuccessful. Watchdogs attribute this lack of interest to alleged mismanagement by Prospect.
In may, Prospect shuttered two Pennsylvania hospitals, Crozer-Chester Medical Center and Taylor Hospital, citing a lack of funds. These closures sparked outrage and calls for increased oversight of corporate ownership in healthcare. The financial struggles of Prospect Medical Systems have drawn scrutiny to the role of private equity in healthcare management and the impact of these financial decisions on patient care and access.
Prospect also remains entangled in litigation with Yale New Haven Health, which seeks to withdraw from a deal to acquire three of prospect’s hospitals, citing financial mismanagement and neglect.
Critics point to prospect’s past relationship with private equity firm Leonard Green & Partners as a contributing factor to its current woes. A Senate report alleged that Leonard Green pushed Prospect to take on excessive debt and prioritize profit maximization,leading to a decline in hospital quality. During Leonard Green’s involvement,Prospect paid out $645 million in dividends and stock redemption to investors,with $424 million going directly to Leonard Green investors.
Sen. Chris Murphy, D-Conn., recently launched a campaign encouraging Connecticut residents to share their experiences with Prospect Medical Holdings’ mismanagement, aiming to build support for greater regulation of private equity in healthcare.
“It was a mistake to let private equity control so much of our health care system, but it’s not too late for us to change course,” said Murphy.
What’s next
The proposed sale to Astrana Health and the ongoing legal battles will likely determine the future of Prospect Medical Systems and its impact on healthcare access in affected communities. Further regulatory scrutiny of private equity involvement in healthcare is also anticipated.